CoChat

Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2

Open access
Takasugi, Masaki, Okada, Ryo, Takahashi, Akiko, Virya Chen, David, Watanabe, Sugiko, Hara, Eiji · 2017 · Nature Communications

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

Cellular senescence prevents the proliferation of cells at risk for neoplastic transformation. However, the altered secretome of senescent cells can promote the growth of the surrounding cancer cells. Although extracellular vesicles (EVs) have emerged as new players in intercellular communication, their role in the function of senescent cell secretome has been largely unexplored. Here, we show that exosome-like small EVs (sEVs) are important mediators of the pro-tumorigenic function of senescent cells. sEV-associated EphA2 secreted from senescent cells binds to ephrin-A1, that is, highly expressed in several types of cancer cells and promotes cell proliferation through EphA2/ephrin-A1 reverse signalling. sEV sorting of EphA2 is increased in senescent cells because of its enhanced phosphorylation resulting from oxidative inactivation of PTP1B phosphatase. Our results demonstrate a novel mechanism of reactive oxygen species (ROS)-regulated cargo sorting into sEVs, which is critical for the potentially deleterious growth-promoting effect of the senescent cell secretome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms15728

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Senescence increases the secretion of sEVs. Immunoblotting of Alix (exosome marker) and CD9 (sEV marker) in the sEV fraction and of phospho-p53 (Ser15), p21 and β-actin in the whole cell lysates (WCL) of pre-senescent control and senescent cells. Senescence was induced by serial passage, oncogenic Ras expression or DXR-treatment in TIG-3 or RPE-1 cells. Dot plots show the relative numbers of sEVs per cell. The number of sEVs in the sEV fraction was quantified using NanoSight. The bottom graphs show the size distributions of sEVs secreted from control and senescent cells. Cell densities were as following at 1 day before starting CM preparation for sEV purification; subconfluent for pre-senescent TIG-3 and RPE-1 cells; 8 × 102 cells cm−2 for replicative senescent TIG-3 cells; 1 × 104 cells cm−2 for Ras-induced senescent TIG-3 cells; 5 × 103 cells cm−2 for DXR-induced senescent TIG-3 cells; 1.4 × 104 cells cm−2 for DXR-induced senescent RPE-1 cells. The CM to be used for sEV purification was prepared by culturing the cells in DMEM supplemented 5% EV-depleted FBS for 3 days. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test).
Figure 1 Senescence increases the secretion of sEVs. Immunoblotting of Alix (exosome marker) and CD9 (sEV marker) in the sEV fraction and of phospho-p53 (Ser15), p21 and β-actin in the whole cell lysates (WCL) of pre-senescent control and senescent cells. Senescence was induced by serial passage, oncogenic Ras expression or DXR-treatment in TIG-3 or RPE-1 cells. Dot plots show the relative numbers of sEVs per cell. The number of sEVs in the sEV fraction was quantified using NanoSight. The bottom graphs show the size distributions of sEVs secreted from control and senescent cells. Cell densities were as following at 1 day before starting CM preparation for sEV purification; subconfluent for pre-senescent TIG-3 and RPE-1 cells; 8 × 102 cells cm−2 for replicative senescent TIG-3 cells; 1 × 104 cells cm−2 for Ras-induced senescent TIG-3 cells; 5 × 103 cells cm−2 for DXR-induced senescent TIG-3 cells; 1.4 × 104 cells cm−2 for DXR-induced senescent RPE-1 cells. The CM to be used for sEV purification was prepared by culturing the cells in DMEM supplemented 5% EV-depleted FBS for 3 days. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test).CC BY · PubMed Central
Figure 2 sEVs secreted from senescent cells promote the proliferation of MCF-7 cells. (a) Relative numbers of MCF-7 cells grown in the presence of CM compared with the number of cells grown in normal medium (DMEM supplemented with 10% FBS). CM was prepared from control (early passage) and replicative senescent (late passage) TIG-3 cells, or control and DXR-induced senescent RPE-1 cells, and was used directly or after depleting EVs by ultracentrifugation. Cell densities of early and late passage TIG-3 cells were 8 × 102 cells cm−2 at 1 day before starting CM preparation. Cell densities of control and DXR-induced senescent RPE-1 cells were 1.4 × 104 cells cm−2 at 1 day before starting CM preparation. MCF-7 cells were plated at a density of 4 × 102 cells cm−2 1 day before starting the experiments. The basal proliferation rate, that is, the fold increase in cell number of untreated MCF-7 cells at culture day 3, was 2.03. The CM to be used for cell culture was prepared by culturing the cells in normal medium for 3 days. Statistical analysis was applied only to the data of culture day 3. (b) Relative numbers of MCF-7 cells grown in the presence of sEVs prepared from control or DXR-induced senescent RPE-1 cells compared with the number of cells grown in normal medium. Pre-senescent RPE-1 cells were subconfluent and DXR-induced senescent RPE-1 cells were at a density of 1.4 × 104 cells cm−2 at 1 day before starting CM preparation. MCF-7 cells were plated at a density of 4 × 102 cells cm−2 1 day before starting the experiments. sEVs were added to the medium at a concentration of 2 × 109 particles per ml. Statistical analysis was applied only to the data of culture day 3. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (one-way ANOVA with the post-hoc Dunnett's two-tailed test for a and two-tailed t-test for b).
Figure 2 sEVs secreted from senescent cells promote the proliferation of MCF-7 cells. (a) Relative numbers of MCF-7 cells grown in the presence of CM compared with the number of cells grown in normal medium (DMEM supplemented with 10% FBS). CM was prepared from control (early passage) and replicative senescent (late passage) TIG-3 cells, or control and DXR-induced senescent RPE-1 cells, and was used directly or after depleting EVs by ultracentrifugation. Cell densities of early and late passage TIG-3 cells were 8 × 102 cells cm−2 at 1 day before starting CM preparation. Cell densities of control and DXR-induced senescent RPE-1 cells were 1.4 × 104 cells cm−2 at 1 day before starting CM preparation. MCF-7 cells were plated at a density of 4 × 102 cells cm−2 1 day before starting the experiments. The basal proliferation rate, that is, the fold increase in cell number of untreated MCF-7 cells at culture day 3, was 2.03. The CM to be used for cell culture was prepared by culturing the cells in normal medium for 3 days. Statistical analysis was applied only to the data of culture day 3. (b) Relative numbers of MCF-7 cells grown in the presence of sEVs prepared from control or DXR-induced senescent RPE-1 cells compared with the number of cells grown in normal medium. Pre-senescent RPE-1 cells were subconfluent and DXR-induced senescent RPE-1 cells were at a density of 1.4 × 104 cells cm−2 at 1 day before starting CM preparation. MCF-7 cells were plated at a density of 4 × 102 cells cm−2 1 day before starting the experiments. sEVs were added to the medium at a concentration of 2 × 109 particles per ml. Statistical analysis was applied only to the data of culture day 3. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (one-way ANOVA with the post-hoc Dunnett's two-tailed test for a and two-tailed t-test for b).CC BY · PubMed Central
Figure 3 Senescence induces increased secretion of sEV-associated EphA2. (a) Comparative proteomic analysis of sEVs secreted from control and DXR-induced senescent RPE-1 cells by using mass spectrometry. The number of peptides detected in sEVs secreted from control and DXR-induced senescent RPE-1 cells are plotted for the identified proteins. Blue and red plots represent the data for the proteins significantly enriched in sEVs secreted from control and DXR-induced senescent RPE-1 cells, respectively. Green plots represent the data for the other proteins. (b) Immunoblotting of EphA2, Alix and β-actin in the sEV fraction and WCL of control and DXR-induced senescent RPE-1 cells. The same number of sEVs was loaded in each lane. Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. (c) Immunoblotting of indicated proteins in the sEV fraction, CM and WCL of DXR-induced senescent RPE-1 cells expressing non-targeting shRNA (shNT) or Rab35 shRNA (shRab35). Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. (d) Immunoblotting of indicated proteins in the sEV fraction and WCL of pre-senescent control and senescent TIG-3 cells. Senescence was induced by serial passage, oncogenic Ras expression or DXR-treatment. The same number of sEVs was loaded in each lane. Dot plots represent the relative density of sEV-associated EphA2 analysed by ImageJ. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test).
Figure 3 Senescence induces increased secretion of sEV-associated EphA2. (a) Comparative proteomic analysis of sEVs secreted from control and DXR-induced senescent RPE-1 cells by using mass spectrometry. The number of peptides detected in sEVs secreted from control and DXR-induced senescent RPE-1 cells are plotted for the identified proteins. Blue and red plots represent the data for the proteins significantly enriched in sEVs secreted from control and DXR-induced senescent RPE-1 cells, respectively. Green plots represent the data for the other proteins. (b) Immunoblotting of EphA2, Alix and β-actin in the sEV fraction and WCL of control and DXR-induced senescent RPE-1 cells. The same number of sEVs was loaded in each lane. Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. (c) Immunoblotting of indicated proteins in the sEV fraction, CM and WCL of DXR-induced senescent RPE-1 cells expressing non-targeting shRNA (shNT) or Rab35 shRNA (shRab35). Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. (d) Immunoblotting of indicated proteins in the sEV fraction and WCL of pre-senescent control and senescent TIG-3 cells. Senescence was induced by serial passage, oncogenic Ras expression or DXR-treatment. The same number of sEVs was loaded in each lane. Dot plots represent the relative density of sEV-associated EphA2 analysed by ImageJ. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test).CC BY · PubMed Central
Figure 4 sEV-associated EphA2 promotes cancer cell proliferation. (a) Immunoblotting shows successful knockdown of EphA2 in DXR-induced senescent RPE-1 cells. The same number of sEVs was loaded in each lane. Dot plot represents the relative numbers of MCF-7 cells grown for 3 days in the presence of sEVs compared with the number of cells grown for 3 days in normal medium. sEVs were purified from DXR-induced senescent RPE-1 cells expressing non-targeting shRNA (shNT) or EphA2 shRNA (shEphA2-1 or shEphA2-2) and added to the medium at a concentration of 2 × 109 particles per ml. (b) Immunoblotting shows successful overexpression of EphA2 in pre-senescent RPE-1 cells. The same number of sEVs was loaded in each lane. Dot plot represents the relative numbers of MCF-7 cells grown for 3 days in the presence of sEVs compared with the number of cells grown for 3 days in normal medium. sEVs were purified from pre-senescent RPE-1 cells expressing empty vector or ectopic EphA2, and added to the medium at a concentration of 2 × 109 particles per ml. (c,d) Relative numbers of MCF-7 cells grown for 3 and 12 days in the presence of CM prepared from (c) DXR-induced senescent RPE-1 cells or (d) DXR-induced senescent TIG-3 cells expressing shNT or shEphA2. Normal medium and CM was renewed every 3 days during the long-term (12 days) culture. (e) Relative numbers of OVK-18, T.T and pre-senescent RPE-1 cells (plated at a density of 4 × 102 cells cm−2 1 day before starting the experiments) grown for 3 days in the presence of sEVs compared with the number of cells grown for 3 days in normal medium. sEVs were purified from DXR-induced senescent RPE-1 cells expressing shNT or shEphA2 and added to the medium at a concentration of 2 × 109 particles per ml. The basal proliferation rates, that is, the fold increase in cell numbers of untreated OVK-18, T.T and RPE-1 cells at culture day 3, were 2.24, 3.48 and 10.72, respectively. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (one-way ANOVA with the post-hoc Dunnett's two-tailed test for a,c,e and two-tailed t-test for b,d).
Figure 4 sEV-associated EphA2 promotes cancer cell proliferation. (a) Immunoblotting shows successful knockdown of EphA2 in DXR-induced senescent RPE-1 cells. The same number of sEVs was loaded in each lane. Dot plot represents the relative numbers of MCF-7 cells grown for 3 days in the presence of sEVs compared with the number of cells grown for 3 days in normal medium. sEVs were purified from DXR-induced senescent RPE-1 cells expressing non-targeting shRNA (shNT) or EphA2 shRNA (shEphA2-1 or shEphA2-2) and added to the medium at a concentration of 2 × 109 particles per ml. (b) Immunoblotting shows successful overexpression of EphA2 in pre-senescent RPE-1 cells. The same number of sEVs was loaded in each lane. Dot plot represents the relative numbers of MCF-7 cells grown for 3 days in the presence of sEVs compared with the number of cells grown for 3 days in normal medium. sEVs were purified from pre-senescent RPE-1 cells expressing empty vector or ectopic EphA2, and added to the medium at a concentration of 2 × 109 particles per ml. (c,d) Relative numbers of MCF-7 cells grown for 3 and 12 days in the presence of CM prepared from (c) DXR-induced senescent RPE-1 cells or (d) DXR-induced senescent TIG-3 cells expressing shNT or shEphA2. Normal medium and CM was renewed every 3 days during the long-term (12 days) culture. (e) Relative numbers of OVK-18, T.T and pre-senescent RPE-1 cells (plated at a density of 4 × 102 cells cm−2 1 day before starting the experiments) grown for 3 days in the presence of sEVs compared with the number of cells grown for 3 days in normal medium. sEVs were purified from DXR-induced senescent RPE-1 cells expressing shNT or shEphA2 and added to the medium at a concentration of 2 × 109 particles per ml. The basal proliferation rates, that is, the fold increase in cell numbers of untreated OVK-18, T.T and RPE-1 cells at culture day 3, were 2.24, 3.48 and 10.72, respectively. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (one-way ANOVA with the post-hoc Dunnett's two-tailed test for a,c,e and two-tailed t-test for b,d).CC BY · PubMed Central
Figure 5 Ephrin-A1 mediates the growth-promoting effect of sEV-associated EphA2. (a) Immunoblotting of EphA2, ephrin-A1 and β-actin in the WCL of indicated cell lines. (b) Relative numbers of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. Normal rabbit IgG or rabbit anti-ephrin-A1 IgG (AER-031; Alomone) was added to the medium at a concentration of 5 μg ml−1. CM was prepared from DXR-induced senescent RPE-1 cells. (c) Immunoblotting shows successful overexpression of ephrin-A1 in MCF-7 cells. Dot plot represents the relative numbers of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. Empty vector or ectopic ephrin-A1 was expressed in MCF-7 cells. CM was prepared from DXR-induced senescent RPE-1 cells. Replicates are biological replicates (n=3 for b and n=5 for c). Error bars indicate s.d. *P<0.05 (two-tailed t-test).
Figure 5 Ephrin-A1 mediates the growth-promoting effect of sEV-associated EphA2. (a) Immunoblotting of EphA2, ephrin-A1 and β-actin in the WCL of indicated cell lines. (b) Relative numbers of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. Normal rabbit IgG or rabbit anti-ephrin-A1 IgG (AER-031; Alomone) was added to the medium at a concentration of 5 μg ml−1. CM was prepared from DXR-induced senescent RPE-1 cells. (c) Immunoblotting shows successful overexpression of ephrin-A1 in MCF-7 cells. Dot plot represents the relative numbers of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. Empty vector or ectopic ephrin-A1 was expressed in MCF-7 cells. CM was prepared from DXR-induced senescent RPE-1 cells. Replicates are biological replicates (n=3 for b and n=5 for c). Error bars indicate s.d. *P<0.05 (two-tailed t-test).CC BY · PubMed Central
Figure 6 sEV-associated EphA2 promotes cancer cell proliferation through EphA2/ephrin-A1 reverse signalling. (a) Immunoblotting of EphA2 and β-actin in the WCL of MCF-7 cells expressing empty vector or ectopic EphA2. Cells were grown for 3 days with or without CM prepared from DXR-induced senescent RPE-1 cells. (b) EphA2 immunoprecipitates prepared from MCF-7 cells expressing ectopic EphA2 were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. The indicated samples were treated with recombinant human ephrin-A1 (500 ng ml−1) for 20 min. Eight-hour pre-treatment with the EphA2 inhibitor ALW-II-41-27 (100 nM) suppressed ephrin-A1-induced EphA2 phosphorylation. (c) Relative numbers of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. DMSO or ALW-II-41-27 (100 nM) was added to the medium. (d) Immunoblotting of phospho-Erk, total-Erk and β-actin in the WCL of MCF-7 cells grown for 3 days with or without CM prepared from control or DXR-induced senescent RPE-1 cells expressing non-targeting shRNA (shNT), shEphA2 or shRab35. (e) The heatmap shows the relative gene expression levels in MCF-7 cells grown for 3 days with or without CM prepared from DXR-induced senescent RPE-1 cells expressing shNT or shEphA2. Genes whose expression levels were changed more than 1.2-fold by the CM of shNT-expressing cells are shown. (f) EphA2-dependent upregulated genes were analysed with oPOSSUM-3. Each circle in the plot shows an enrichment of the targets of a different transcription factor. (g) Immunoblotting of phospho-Erk, total-Erk and β-actin in the WCL of MCF-7 cells grown for 3 days with or without CM. Dot plot represents the number of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. DMSO or U0126 (500 nM) was added to the medium. CM was prepared from DXR-induced senescent RPE-1 cells. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test).
Figure 6 sEV-associated EphA2 promotes cancer cell proliferation through EphA2/ephrin-A1 reverse signalling. (a) Immunoblotting of EphA2 and β-actin in the WCL of MCF-7 cells expressing empty vector or ectopic EphA2. Cells were grown for 3 days with or without CM prepared from DXR-induced senescent RPE-1 cells. (b) EphA2 immunoprecipitates prepared from MCF-7 cells expressing ectopic EphA2 were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. The indicated samples were treated with recombinant human ephrin-A1 (500 ng ml−1) for 20 min. Eight-hour pre-treatment with the EphA2 inhibitor ALW-II-41-27 (100 nM) suppressed ephrin-A1-induced EphA2 phosphorylation. (c) Relative numbers of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. DMSO or ALW-II-41-27 (100 nM) was added to the medium. (d) Immunoblotting of phospho-Erk, total-Erk and β-actin in the WCL of MCF-7 cells grown for 3 days with or without CM prepared from control or DXR-induced senescent RPE-1 cells expressing non-targeting shRNA (shNT), shEphA2 or shRab35. (e) The heatmap shows the relative gene expression levels in MCF-7 cells grown for 3 days with or without CM prepared from DXR-induced senescent RPE-1 cells expressing shNT or shEphA2. Genes whose expression levels were changed more than 1.2-fold by the CM of shNT-expressing cells are shown. (f) EphA2-dependent upregulated genes were analysed with oPOSSUM-3. Each circle in the plot shows an enrichment of the targets of a different transcription factor. (g) Immunoblotting of phospho-Erk, total-Erk and β-actin in the WCL of MCF-7 cells grown for 3 days with or without CM. Dot plot represents the number of MCF-7 cells grown for 3 days in the presence of CM compared with the number of cells grown for 3 days in normal medium. DMSO or U0126 (500 nM) was added to the medium. CM was prepared from DXR-induced senescent RPE-1 cells. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test).CC BY · PubMed Central
Figure 7 EphA2 phosphorylation facilitates its sorting into sEVs in senescent cells. (a) EphA2 immunoprecipitates prepared from control and DXR-induced senescent RPE-1 cells were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. Dot plot represents the relative density of phospho-EphA2/EphA2 analysed by ImageJ. (b) Immunoblotting of indicated proteins in the sEV fraction and WCL of DXR-induced senescent RPE-1 cells expressing wild-type or phospho-resistant EphA2 tagged with FLAG. Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. (c) Relative PTP1B activity in control and DXR-induced senescent RPE-1 cells. (d) Relative PTP1B activity in DXR-induced senescent RPE-1 cells expressing empty vector or ectopic PTP1B. (e) Immunoprecipitates prepared from control and DXR-induced senescent RPE-1 cells expressing empty vector or ectopic PTP1B were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. Dot plot represents the relative density of phospho-EphA2/EphA2 analysed by ImageJ. (f) Immunoblotting of indicated proteins in the sEV fraction and WCL of DXR-induced senescent RPE-1 cells expressing empty vector or ectopic PTP1B. Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test for a–d,f and one-way ANOVA with the post-hoc Dunnett's two-tailed test for e).
Figure 7 EphA2 phosphorylation facilitates its sorting into sEVs in senescent cells. (a) EphA2 immunoprecipitates prepared from control and DXR-induced senescent RPE-1 cells were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. Dot plot represents the relative density of phospho-EphA2/EphA2 analysed by ImageJ. (b) Immunoblotting of indicated proteins in the sEV fraction and WCL of DXR-induced senescent RPE-1 cells expressing wild-type or phospho-resistant EphA2 tagged with FLAG. Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. (c) Relative PTP1B activity in control and DXR-induced senescent RPE-1 cells. (d) Relative PTP1B activity in DXR-induced senescent RPE-1 cells expressing empty vector or ectopic PTP1B. (e) Immunoprecipitates prepared from control and DXR-induced senescent RPE-1 cells expressing empty vector or ectopic PTP1B were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. Dot plot represents the relative density of phospho-EphA2/EphA2 analysed by ImageJ. (f) Immunoblotting of indicated proteins in the sEV fraction and WCL of DXR-induced senescent RPE-1 cells expressing empty vector or ectopic PTP1B. Dot plot represents the relative density of sEV-associated EphA2 analysed by ImageJ. Replicates are biological replicates (n=3). Error bars indicate s.d. *P<0.05 (two-tailed t-test for a–d,f and one-way ANOVA with the post-hoc Dunnett's two-tailed test for e).CC BY · PubMed Central
Figure 8 Increased ROS induce EphA2 phosphorylation via PTP1B inactivation. (a) Intracellular ROS levels were measured by DCF fluorescence in RPE-1 cells treated with or without DXR and NAC. NAC was added to the medium 6 h before analysis at a concentration of 2 mM. (b) Oxidized-PTP1B was immunoprecipitated by scFvs45 antibody from RPE-1 cells treated with or without DXR and NAC. Inputs and immunoprecipitates were immunoblotted with anti-PTP1B antibody. Dot plot represents the relative density of oxidized-PTP1B/PTP1B analysed by ImageJ. (c) Relative PTP1B activity in RPE-1 cells treated with or without DXR and NAC. (d) EphA2 immunoprecipitates prepared from RPE-1 cells treated with or without DXR and NAC were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. Dot plot represents the relative density of phospho-EphA2/EphA2 analysed by ImageJ. (e) Schematic model of the regulation and function of sEV-associated EphA2 in senescent cells. Replicates are biological replicates (n=3 for a,b,d and n=4 for c). Error bars indicate s.d. *P<0.05 (one-way ANOVA with the post-hoc Dunnett's two-tailed test for a–c) and two-tailed t-test for d).
Figure 8 Increased ROS induce EphA2 phosphorylation via PTP1B inactivation. (a) Intracellular ROS levels were measured by DCF fluorescence in RPE-1 cells treated with or without DXR and NAC. NAC was added to the medium 6 h before analysis at a concentration of 2 mM. (b) Oxidized-PTP1B was immunoprecipitated by scFvs45 antibody from RPE-1 cells treated with or without DXR and NAC. Inputs and immunoprecipitates were immunoblotted with anti-PTP1B antibody. Dot plot represents the relative density of oxidized-PTP1B/PTP1B analysed by ImageJ. (c) Relative PTP1B activity in RPE-1 cells treated with or without DXR and NAC. (d) EphA2 immunoprecipitates prepared from RPE-1 cells treated with or without DXR and NAC were immunoblotted with anti-phosphotyrosine and anti-EphA2 antibody. Dot plot represents the relative density of phospho-EphA2/EphA2 analysed by ImageJ. (e) Schematic model of the regulation and function of sEV-associated EphA2 in senescent cells. Replicates are biological replicates (n=3 for a,b,d and n=4 for c). Error bars indicate s.d. *P<0.05 (one-way ANOVA with the post-hoc Dunnett's two-tailed test for a–c) and two-tailed t-test for d).CC BY · PubMed Central
Figure 9 EphA2 expression is increased in the stroma of breast and ovarian cancers. The left boxplot shows EphA2 mRNA expression levels in normal breast stroma (n=6) and breast cancer stroma (n=26). The right boxplot shows EphA2 mRNA expression levels in normal ovarian stroma (n=8) and ovarian cancer stroma (n=31). *P<0.05 (Wilcoxon test).
Figure 9 EphA2 expression is increased in the stroma of breast and ovarian cancers. The left boxplot shows EphA2 mRNA expression levels in normal breast stroma (n=6) and breast cancer stroma (n=26). The right boxplot shows EphA2 mRNA expression levels in normal ovarian stroma (n=8) and ovarian cancer stroma (n=31). *P<0.05 (Wilcoxon test).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

Items 201–300 of 416

Metadata

Authors
Takasugi, M., Okada, R., Takahashi, A., Virya Chen, D., Watanabe, S., & Hara, E.
Affiliations
  • Research Institute for Microbial Diseases, The University of Osaka (JP)
  • Japanese Foundation For Cancer Research (JP)
Corresponding author
  • Takasugi, Masaki
  • Hara, Eiji
Venue
Nature Communications
Published
2017-06-06
Volume
8
Issue
1
Pages
15729-15729
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2623712984
Cited by
410
References
53
Citations by year
2026: 34 · 2025: 51 · 2024: 61 · 2023: 43 · 2022: 47 · 2021: 57 · 2020: 53 · 2019: 36 · 2018: 23 · 2017: 5
FWCI
13.07
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science (16H04700, 17K19618)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
cellular senescence, senescence-associated secretome, small extracellular vesicles, exosomes, EphA2, ephrin-A1, tumor cell proliferation, PTP1B, oxidative inactivation, reactive oxygen species, cargo sorting, intercellular communication, carcinogenesis
MeSH terms
Breast Neoplasms, Female, Humans, Ovarian Neoplasms, Phosphorylation, Recombinant Proteins, Mass Spectrometry, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Reactive Oxygen Species, Oligonucleotide Array Sequence Analysis, Receptor, EphA2, Ephrin-A2, Cell Line, Tumor, Cell Proliferation, Protein Tyrosine Phosphatase, Non-Receptor Type 1, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.